Skip to main content
Clinical Trials/EUCTR2004-002821-30-LT
EUCTR2004-002821-30-LT
Active, not recruiting
Not Applicable

Study of the efficacy of intravesical instillations of interleukin-2 in treatment of superficial bladder cancer

Institute of Oncology, Vilnius University0 sites70 target enrollmentOctober 11, 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Institute of Oncology, Vilnius University
Enrollment
70
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2004
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Institute of Oncology, Vilnius University

Eligibility Criteria

Inclusion Criteria

  • 1\. Signed patient informed consent form
  • 2\. Histologically confirmed diagnosis of multifocal Ta,T1 /G1,G2 superficial bladder cancer
  • 3\. WHO\-performance status 0\-2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. The presence of a cancer type other than transitional cell carcinoma
  • 2\. Previous intravesical chemotherapy within 3 months before treatment
  • 3\. Previous radiotherapy to the bladder
  • 4\. Urinary tract infection
  • 5\. Decompensated cardiovascular, renal or liver diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials